Integra LifeSciences修订了Q4收入指南,并任命Mojdeh Poul为新的首席执行官。 Integra LifeSciences revises Q4 earnings guidance and appoints Mojdeh Poul as new CEO.
Integra LifeSciences修订了其Q4收入指南,预测收入4.41至4.51亿美元的每股收入为0.81至0.89美元。 Integra LifeSciences has revised its Q4 earnings guidance, projecting $0.81 to $0.89 per share on revenues of $441 to $451 million. 对于2024财政年度,它预计每股收入在2.41至2.49美元之间。 For FY 2024, it anticipates earnings between $2.41 and $2.49 per share. 此外,该公司任命Mojdeh Poul为总裁兼首席执行官,2025年1月6日生效,接替Jan De Witte。 Additionally, the company appointed Mojdeh Poul as president and CEO, effective January 6, 2025, succeeding Jan De Witte. Poul在医疗保健方面已超过25年,目的是加强Integra的业务和质量战略。 Poul, with over 25 years in healthcare, aims to enhance Integra’s operational and quality strategies.